Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients

BACKGROUND: Current clinical trials demonstrated that combination regimens comprising chemotherapy and immunotherapy lead to better patient outcomes compared to chemotherapy alone as the first line of treatment for non-small cell lung cancer (NSCLC). In addition, the combination therapy of docetaxel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: Yoshimura, Akihiro, Yamada, Tadaaki, Okuma, Yusuke, Kitadai, Rui, Takeda, Takayuki, Kanematsu, Takanori, Goto, Hisatsugu, Yoneda, Hiroto, Harada, Taishi, Kubota, Yutaka, Yamada, Takahiro, Date, Koji, Shiotsu, Shinsuke, Nagata, Kazuhiro, Chihara, Yusuke, Kaneko, Yoshiko, Uchino, Junji, Nishioka, Yasuhiko, Takayama, Koichi
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6749132/
https://ncbi.nlm.nih.gov/pubmed/31555518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.08.07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados